Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | RGT-490 |
| Synonyms | |
| Therapy Description |
RGT-490 is a mutant-selective PIK3CA inhibitor, which potentially induces apoptosis and inhibits proliferation of tumor cells (Cancer Res (2026) 86 (7_Supplement): 4571). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| RGT-490 | RGT490|RGT 490 | PIK3CA inhibitor 29 | RGT-490 is a mutant-selective PIK3CA inhibitor, which potentially induces apoptosis and inhibits proliferation of tumor cells (Cancer Res (2026) 86 (7_Supplement): 4571). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07524322 | Phase I | RGT-490 | Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors | Recruiting | USA | 0 |